FindTrial
Sign In

Risk factors and prognosis of invasive pulmonary aspergillosis (IPA) in critically ill neocoronary patients in the ICU

Risk factors and prognosis of invasive pulmonary aspergillosis (IPA) in critically ill neocoronary patients in the ICU

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098190
Enrollment
Unknown
Registered
2025-03-04
Start date
2024-03-29
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Pulmonary Aspergillosis

Interventions

CAPA group/non-CAPA group:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Positive RT-PCR test for novel coronavirus (throat swab); 2.Age >= 18 years old;

Exclusion criteria

Exclusion criteria: 1.Length of ICU stay <= 48 hours; 2.ICU admission for trauma or postoperative without symptoms of viral infection; 3.Pregnant; 4.Failure to perform mycological testing;

Design outcomes

Primary

MeasureTime frame
Galactomannan;Next generation sequencing;Microbiological culture;Lung histopathology;—

Secondary

MeasureTime frame
Chest CT;Chest X-ray;Fiberoptic bronchoscopy;White blood cell;Neutrophils;Lymphocyte;Hemoglobin;Platelet;Erythrocyte sedimentation rate;C-reactive protein;Procalcitonin;Interleukin-6;Ferritin;Alanine aminotransferase;Aspartate aminotransferase;Creatinine;Blood urea nitrogen;Acute Physiology and Chronic Health Evaluation;Sequential Organ Failure Assessment;Height;Weight;—

Countries

China

Contacts

Public ContactChen Xiaomei

Qilu Hospital of Shandong University

chenxm008@163.com+86 18560081002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026